Ser124

Site Information
ssMVsEtstAGTAST SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 4720371

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	liver cancer ( 2 )
Relevant cell line - cell type - tissue:	Jurkat (T lymphocyte) ( 1 ) , liver ( 2 )

References
1	Guo A (2011) CST Curation Set: 11888; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P Curated Info
2	Tucker M (2010) CST Curation Set: 8914; Year: 2010; Biosample/Treatment: tissue, liver/untreated; Disease: liver cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P Curated Info